by Seini Moimoi | Nov 28, 2018
Inflazome is developing a portfolio of NLRP3 inhibitors to treat inflammation driven diseases. 
by Seini Moimoi | Nov 12, 2018
Nabriva is a biotechnology company focused on the development of novel anti-infective agents to treat serious infections. 
by Seini Moimoi | Nov 8, 2018
89Bio is a biopharmaceutical company focused on nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders. 
by Seini Moimoi | Aug 29, 2018
KaNDy is developing NT-814 for the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause. 
by Seini Moimoi | May 22, 2018
Sublimity Therapeutics is a biotechnology company developing therapies for the treatment of ulcerative colitis.